Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of a bivalent Pseudomonas aeruginosa flagella vaccine in cystic fibrosis
ISRCTN98785888Phase 3Completed
- Sponsor
- Vaincre la Mucoviscidose
- Start
- May 1997
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, randomised, double-blind trial in Pseudomonal infection and cystic fibrosis (CF) comparing Bivalent Pseudomonas aeruginosa flagella vaccine with Placebo (2 arms). Primary endpoints: Primary endpoint 1 and Primary endpoint 2. Started May 1997; status: completed.
02
Drugs
bivalent Pseudomonas aeruginosa flagella vaccine
03
Conditions
Pseudomonal infectioncystic fibrosis (CF)
Beyond the preview
Go deeper on ISRCTN98785888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN98785888.